As reported in Globes: Medtronic has invested $2 million in Israeli company DreaMed Diabetes, and signed a development and marketing deal with it. The Medtronic MiniMed 640G detects when blood sugar levels are falling and stops insulin from being produced. In people with diabetes, the pancreas doesn’t work like it’s supposed to. Current devices allow insulin pumps to deliver insulin after a reading from a glucose meter. The device — which the team doesn’t describe on a physical level, but most likely looks like a small box —would monitor and adjust a user’s blood sugar levels without them needing a bunch of different equipment to do so. Schematic overview of a closed-loop AP. Use of the MD-Logic algorithm has significantly decreased patients’ time spent in hypoglycemia and increased their time spent in-range in overnight and 24-hours/day use.
The level of innovation has been very vast,” Dr Hovorka told Medscape Medical News. There are several marketed systems